Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
COVID-19 patients are at high risk for both capillary micro thrombi and large vessel thrombosis. Anticoagulant administration in COVID-19 patients, especially in ICU setting, is recommended by some researchers. However, clinical guidelines don't yet recommend anticoagulation therapies in therap...
Main Authors: | Amir Javid, Reza Kazemi, Mehdi Dehghani, Hossein Bahrami Samani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Urology Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214442021000085 |
Similar Items
-
Anticoagulant prophylaxis and therapy in patients with COVID-19
by: Nikolay Runev, et al.
Published: (2021-04-01) -
Fatal retroperitoneal hematoma associated with Covid-19 prophylactic anticoagulation protocol
by: Michael Teta, PA, et al.
Published: (2021-07-01) -
New anticoagulant therapy aspects to the COVID-19 patients: From prophylaxis to complications treatment therapy
by: Đenić Aleksandar
Published: (2021-01-01) -
Ovarian Artery Rupture Presenting with a Spontaneous Retroperitoneal Hemorrhage of an Anticoagulated Patient: A Successful Treatment with Embolization
by: So Jeong Lee, et al.
Published: (2020-11-01) -
Catastrophic antiphospholipid COVID-19 syndrome
by: Yu. S. Polushin, et al.
Published: (2021-03-01)